SlideShare a Scribd company logo
10 TIPS to Approach a Pregnant
lady on Hemodialysis
Emad Magdy Shawky
Assistant lecturer of Nephrology
MNDU
Hemodialysis Course, 22th DEC. 2016
CHANCE
Kidney Int. 2016 May;89(5)
1
Hormonal changes (Estrogen- progesterone- LH-
Prolactine)
 Anovulation ( with or without Amenorrhea)
 Endometrial changes
CHANCE
Kidney Int. 2016 May;89(5)
1
The Miracle Continues
Against All Odds
CHANCE1
Increasing incidence
 May reach 7% of women on CHD rising from 1% 1980 (Improving Dx service, better
anemia control)
 More with residual renal function.
 Less with PD.
Increasing survival rates
 1st successful 1971
 30-50% increasing dialysis dose
 85% premature
 35% LBW ( < 2kg)
 Common complications : Respiratory distress- CP- Congenital anomalies
Kidney Int. 2016 May;89(5)
CONTRACEPTION2
Medical, Ethical, And Emotional
Complexities
Am J Kidney Dis. 2015 Dec;66(6):951-61
CONTRACEPTION2
CONTRACEPTION2
Counselling tips for dialysis or pre-dialysis patients who wish
to undertake a pregnancy
 Counselling on pregnancy and contraception should be included in the approach
to all women in childbearing age who start dialysis (not graded).
 The prognostic markers allowing quantification of the probability of a successful
pregnancy are only partially known. Residual kidney function and
normotension are favourable prognostic factors (not graded).
 Counselling should also include the fact that outcomes of pregnancy are better
after transplantation than on dialysis (strong suggestion from large studies in
transplanted patients, and from Registries).
CONTRACEPTION2
Historically, renal disease was considered a contraindication to
pregnancy, but now many pregnant women with CKD have
successful outcomes
Am J Kidney Dis. 2015 Dec;66(6):951-61
The key pre-pregnancy factors predicting outcome include
the following:
Degree of renal impairment rather than the aetiology of
renal disease.
Control of hypertension
Degree of proteinuria
CONTRACEPTION2
CONTRACEPTION2
• HTN, PET, Anemia,
progression to ESRD
• Placental Hge,
polyhydramnios, PROM
Maternal
• Prematurity, LBW, IUGR, CP, Cong
anomalies
• Neonatal death, abortion
Fetal
Hippokratia. 2011 Jan; 15 (Suppl 1): 8–12.
CONTRACEPTION2
CONTRACEPTION2
CONTRACEPTION2
CONTRACEPTION2
IUD
Bleeding- Infection
Oral contraceptives
Hypercoagulability (access)
Barriers
Safety
ACKD Journal, Vol 20, No 3 (May), 2013
CONTRACEPTION2
IUD
Bleeding- Infection
Oral contraceptives
Hypercoagulability (access)
Barriers
Safety
ACKD Journal, Vol 20, No 3 (May), 2013
Difficult
 Pregnancy is often unexpected
 Symptoms in the early phase may mimic different diseases and complications
of dialysis.
 Serum levels of beta-HCG may be increased even in the absence of pregnancy.
 Irregular menstrual cycles and anovulation are common in women on
dialysis,thus making the calculation of gestational age based upon the last
menstrual cycle unreliable.
In this context, early ultrasonography should be used to verify the
presence of a viable foetus and to calculate the gestational age.
Gianfranco Manisco,et al. clin kidney J (2015)
3 Diagnosis of pregnancy in dialysis
Challenges In Prescription4
Plasma volume Increased by 30% >>
hemodilution>>anemia
WT gain rate plasma vol plus fetal and placental develop
Polyhydramnios as high BUN>>fetal osmotic diuresis
 Bone and mineral metabolism placenta converts some 25-
hydroxyvitamin D3 to 1,25-dihydroxyvitamin
D3>>adjustment of vitamin D , Ca supplement
Respiratory alkalosis hyperventilation (progest mechanical) –
hyperemesis>>> compensation by M.Acidosis
EPO resistance , cytokine release >> anemia
DOSE AND ADEQUACY4.a.
Nephrol Dial Transplant (2015) 0: 1–20
Target BUN < 50 mg/dL
or even < 45 mg/dL
DOSE AND ADEQUACY4.a.
Recently, the relationship between dialysis intensity and outcomes has become
clearer, with increased dialysis delivery becoming standard practice and nocturnal
hemodialysis potentially providing superior fertility and outcomes.
Shilpanjali Jesudson, et al. Clin J Am Soc Nephrol 9: 143–149, 2014.
DOSE AND ADEQUACY
Hippokratia. 2011 Jan; 15 (Suppl 1): 8–12.
4.a.
J Am Soc Nephrol. 2014; 25:1103–1109.
4.a.
J Am Soc Nephrol. 2014; 25:1103–1109.
4.a.
J Am Soc Nephrol. 2014; 25:1103–1109.
4.a.
Dialyzer type, ultrafiltration volume
Small surface area dialysers
Reduce UF rate per session
Avoid hypotension
Avoid abrupt osmolarity changes
4.b.
High surface area membranes
Dialyzer type, ultrafiltration volume
Dry BW assessment
Predicted Wt gain: after 3m>> 0.5 Kg/wk
Clinical: Bp control, (edema not reliable)
Hematocrit & Albumin levels
Measure Hematocrit & Albumin at the initial first-
trimester visit.
4.b.
A rise in either value strongly suggests
intravascular volume contraction, Opposite is
not trueAdvances in Chronic Kidney Disease, Vol 20, No 3 (May), 2013
Heparin
Pregnancy is a hypercoagulability state so
theoretically there are increased requirements but
it is not a rule.
4.c.
Individualization
Hemodialysis International 2016; 20:339–348.
Dialysate constituents
• 3 meq/l
• Intensive
dialysis with
risk of
hypokalemia
• <25 meq/l
• Target
serum18-22
mmol/l
• 135 mmol/l
4.d.
Hemodialysis International 2016; 20:339–348
.
Minerals and water soluble vitamins
Give at increased doses, because
they can be partially removed by
intensive dialysis.
Folic acid at a higher dose of 5
mg daily if on dialysis
4.e.
Hemodialysis International 2016; 20:339–348
BMD
Phosphate: monitored frequently- may stop
phosphate binders or need supplementation
(important to fetal skeletal development)
Calcium: increase dialysate calcium to 1.75 mmol/l –
oral supplementation (1-2 g/d)- take care of hyper
or hypocalcemia
5
placenta converts some 25-hydroxyvitamin D3
to 1,25-dihydroxyvitamin D3
Kidney Int. 2016 May;89(5)
Anemia6
Target : 11g/dl.
EPO : increase dose by 50%.
Iron : monitored monthly ( IV supp).
CBC weekly.
<8g/dl>> blood trasnfusion. Kidney Int. 2016 May;89(5)
Hypertension And Superimposed PET
Target BP 110-140/80-90 mmHg
7
Superimposed Preeclampsia
Kavitha Vellanki. Advances in Chronic Kidney Disease, 2013.
Difficult Diagnosis
7
 Already patient has renal impairment ± proteinuria ± the absence
of significant urine output if late stage CKD or 5D
 Hypertension, ↓ GFR or proteinuria can be due to progression
of the renal disorder rather than superimposed preeclampsia
When to suspect pre-eclampsia?
 Unexplained rise in BP not responding to fluid removal &
drugs
 Development of classic preeclampsia symptoms (visual
abnormalities severe headache, epigastric pain & hyper-
reflexia)
 Fetal growth restriction and abnormal umbilical artery blood
flow (uterine artery doppler).
 Laboratory abnormalities consistent with the HELLP
syndrome & thrombocytopenia
7
after 20 weeks of pregnancy
Advances in Chronic Kidney Disease, Vol 20, No 3 (May), 2013
Aspirin (75–150 mg/day)
The aim of aspirin is for the prevention
of preeclampsia or perinatal death
Fetal Assessment
Serial ultrasound examinations are important for the
early detection fetal growth restriction
Assessment of the fetal heart rate (particularly
during the last portion of a session)
8
Kidney Int. 2016 May;89(5)
Maternal haemodynamic instability may compromise the
uteroplacental circulation and may be associated with the
induction of uterine contractions
Nutrition9
Attention to nutritional considerations is essential for a
successful pregnancy because malnutrition is common
in pregnancies of ESRD patients
G. Manisco et al. Clin Kidney J (2015) 0: 1–7
Nutrition
Provide protein intake of 1.2–1.4 g/kg pre-pregnancy
weight/day + 20 g/day
Provide calories intake of 25–35 kcal/kg/pregnant
weight/day
Provide water-soluble vitamins supplementation
The main vitamins to be supplemented are vitamin C, thiamine, riboflavin,
niacin and vitamin B6
9
G. Manisco et al. Clin Kidney J (2015) 0: 1–7
Breast Feeding10
PLoS One. 2015 Nov 16;10(11)
 Significant variations in breast milk composition between pre-
and post-HD samples suggest that breastfeeding might be
preferably performed after dialysis treatment.
 In summary, our findings indicate that breastfeeding can be
considered a viable option for newborns of mothers on dialysis.
10 TIPS to Approach a Pregnant lady on Hemodialysis

More Related Content

What's hot

Uric acid and CKD (Consequences, Management and Evidence) - Dr. Gawad
Uric acid and CKD (Consequences, Management and Evidence) - Dr. GawadUric acid and CKD (Consequences, Management and Evidence) - Dr. Gawad
Uric acid and CKD (Consequences, Management and Evidence) - Dr. Gawad
NephroTube - Dr.Gawad
 
CKD (Pathogensis and Progression) - Dr. Gawad
CKD (Pathogensis and Progression) - Dr. GawadCKD (Pathogensis and Progression) - Dr. Gawad
CKD (Pathogensis and Progression) - Dr. Gawad
NephroTube - Dr.Gawad
 
Nutrition in ckd &amp; hd dawly 2017
Nutrition in ckd &amp; hd  dawly 2017Nutrition in ckd &amp; hd  dawly 2017
Nutrition in ckd &amp; hd dawly 2017
FarragBahbah
 
CKD MBD - Think Outside The Box - Case Scenarios Snapshots - Dr. Gawad
CKD MBD - Think Outside The Box - Case Scenarios Snapshots  - Dr. GawadCKD MBD - Think Outside The Box - Case Scenarios Snapshots  - Dr. Gawad
CKD MBD - Think Outside The Box - Case Scenarios Snapshots - Dr. Gawad
NephroTube - Dr.Gawad
 
Renal transplantation and pregnancy
Renal transplantation and pregnancyRenal transplantation and pregnancy
Renal transplantation and pregnancy
Salwa Ibrahim
 
CKD and pregnancy, Moh'd sharshir
CKD and pregnancy, Moh'd sharshirCKD and pregnancy, Moh'd sharshir
CKD and pregnancy, Moh'd sharshir
Moh'd sharshir
 
Anemia management in CKD (ESA Therapy) - Dr. Gawad
Anemia management in CKD (ESA Therapy) - Dr. GawadAnemia management in CKD (ESA Therapy) - Dr. Gawad
Anemia management in CKD (ESA Therapy) - Dr. Gawad
NephroTube - Dr.Gawad
 
Impact of gender and gender disparities in patients with kidney disease
Impact of gender and gender disparities in patients with kidney diseaseImpact of gender and gender disparities in patients with kidney disease
Impact of gender and gender disparities in patients with kidney disease
Muhammad Husnain
 
Case presentation dr ibrihem el negar
Case presentation dr ibrihem el negarCase presentation dr ibrihem el negar
Case presentation dr ibrihem el negar
FarragBahbah
 
CKD Progression (Pharmacological Approach) - Dr. Gawad
CKD Progression (Pharmacological Approach) - Dr. GawadCKD Progression (Pharmacological Approach) - Dr. Gawad
CKD Progression (Pharmacological Approach) - Dr. Gawad
NephroTube - Dr.Gawad
 
Sickle Cell Disease
Sickle Cell DiseaseSickle Cell Disease
Sickle Cell Disease
Usama Ragab
 
Diabetic Nephropathy;Physiotherapy approach, a case report
Diabetic Nephropathy;Physiotherapy approach, a case reportDiabetic Nephropathy;Physiotherapy approach, a case report
Diabetic Nephropathy;Physiotherapy approach, a case report
enweluntaobed
 
Nodat
NodatNodat
Hyperprolactinemia Quiz - Case Presentation
Hyperprolactinemia Quiz - Case PresentationHyperprolactinemia Quiz - Case Presentation
Hyperprolactinemia Quiz - Case Presentation
Usama Ragab
 
Is it Hepatorenal Syndrome? - Dr. Gawad
Is it Hepatorenal Syndrome? - Dr. GawadIs it Hepatorenal Syndrome? - Dr. Gawad
Is it Hepatorenal Syndrome? - Dr. Gawad
NephroTube - Dr.Gawad
 
Reverse Epidemiology of Obesity in Hemodialysis Patients (Obesity Paradox) - ...
Reverse Epidemiology of Obesity in Hemodialysis Patients (Obesity Paradox) - ...Reverse Epidemiology of Obesity in Hemodialysis Patients (Obesity Paradox) - ...
Reverse Epidemiology of Obesity in Hemodialysis Patients (Obesity Paradox) - ...
NephroTube - Dr.Gawad
 
Malnutrition , inflammation ,and atherosclerosis (MIA syndrome in heamodialy...
Malnutrition , inflammation ,and atherosclerosis (MIA syndrome  in heamodialy...Malnutrition , inflammation ,and atherosclerosis (MIA syndrome  in heamodialy...
Malnutrition , inflammation ,and atherosclerosis (MIA syndrome in heamodialy...
dr_ekbalabohashem
 

What's hot (20)

Uric acid and CKD (Consequences, Management and Evidence) - Dr. Gawad
Uric acid and CKD (Consequences, Management and Evidence) - Dr. GawadUric acid and CKD (Consequences, Management and Evidence) - Dr. Gawad
Uric acid and CKD (Consequences, Management and Evidence) - Dr. Gawad
 
CKD (Pathogensis and Progression) - Dr. Gawad
CKD (Pathogensis and Progression) - Dr. GawadCKD (Pathogensis and Progression) - Dr. Gawad
CKD (Pathogensis and Progression) - Dr. Gawad
 
Nutrition in ckd &amp; hd dawly 2017
Nutrition in ckd &amp; hd  dawly 2017Nutrition in ckd &amp; hd  dawly 2017
Nutrition in ckd &amp; hd dawly 2017
 
CKD MBD - Think Outside The Box - Case Scenarios Snapshots - Dr. Gawad
CKD MBD - Think Outside The Box - Case Scenarios Snapshots  - Dr. GawadCKD MBD - Think Outside The Box - Case Scenarios Snapshots  - Dr. Gawad
CKD MBD - Think Outside The Box - Case Scenarios Snapshots - Dr. Gawad
 
Renal transplantation and pregnancy
Renal transplantation and pregnancyRenal transplantation and pregnancy
Renal transplantation and pregnancy
 
CKD and pregnancy, Moh'd sharshir
CKD and pregnancy, Moh'd sharshirCKD and pregnancy, Moh'd sharshir
CKD and pregnancy, Moh'd sharshir
 
Renal disorders in pregnancy
Renal disorders in pregnancyRenal disorders in pregnancy
Renal disorders in pregnancy
 
Anemia management in CKD (ESA Therapy) - Dr. Gawad
Anemia management in CKD (ESA Therapy) - Dr. GawadAnemia management in CKD (ESA Therapy) - Dr. Gawad
Anemia management in CKD (ESA Therapy) - Dr. Gawad
 
Impact of gender and gender disparities in patients with kidney disease
Impact of gender and gender disparities in patients with kidney diseaseImpact of gender and gender disparities in patients with kidney disease
Impact of gender and gender disparities in patients with kidney disease
 
Case presentation dr ibrihem el negar
Case presentation dr ibrihem el negarCase presentation dr ibrihem el negar
Case presentation dr ibrihem el negar
 
CKD Progression (Pharmacological Approach) - Dr. Gawad
CKD Progression (Pharmacological Approach) - Dr. GawadCKD Progression (Pharmacological Approach) - Dr. Gawad
CKD Progression (Pharmacological Approach) - Dr. Gawad
 
Sickle Cell Disease
Sickle Cell DiseaseSickle Cell Disease
Sickle Cell Disease
 
Diabetic Nephropathy;Physiotherapy approach, a case report
Diabetic Nephropathy;Physiotherapy approach, a case reportDiabetic Nephropathy;Physiotherapy approach, a case report
Diabetic Nephropathy;Physiotherapy approach, a case report
 
Hypertension in pregnancy acog 2013
Hypertension in pregnancy acog 2013Hypertension in pregnancy acog 2013
Hypertension in pregnancy acog 2013
 
Nodat
NodatNodat
Nodat
 
Hyperprolactinemia Quiz - Case Presentation
Hyperprolactinemia Quiz - Case PresentationHyperprolactinemia Quiz - Case Presentation
Hyperprolactinemia Quiz - Case Presentation
 
Is it Hepatorenal Syndrome? - Dr. Gawad
Is it Hepatorenal Syndrome? - Dr. GawadIs it Hepatorenal Syndrome? - Dr. Gawad
Is it Hepatorenal Syndrome? - Dr. Gawad
 
Reverse Epidemiology of Obesity in Hemodialysis Patients (Obesity Paradox) - ...
Reverse Epidemiology of Obesity in Hemodialysis Patients (Obesity Paradox) - ...Reverse Epidemiology of Obesity in Hemodialysis Patients (Obesity Paradox) - ...
Reverse Epidemiology of Obesity in Hemodialysis Patients (Obesity Paradox) - ...
 
Dr obrador nc ds ckd prev & keep mexico v2 ac 1 25-13
Dr obrador nc ds ckd prev & keep mexico v2 ac 1 25-13Dr obrador nc ds ckd prev & keep mexico v2 ac 1 25-13
Dr obrador nc ds ckd prev & keep mexico v2 ac 1 25-13
 
Malnutrition , inflammation ,and atherosclerosis (MIA syndrome in heamodialy...
Malnutrition , inflammation ,and atherosclerosis (MIA syndrome  in heamodialy...Malnutrition , inflammation ,and atherosclerosis (MIA syndrome  in heamodialy...
Malnutrition , inflammation ,and atherosclerosis (MIA syndrome in heamodialy...
 

Viewers also liked

Holloway Willard C (technical updated)
Holloway Willard C (technical updated)Holloway Willard C (technical updated)
Holloway Willard C (technical updated)Wil Holloway
 
Profile Que Lam 2016
Profile Que Lam 2016Profile Que Lam 2016
Profile Que Lam 2016Annie Tong
 
amos_puckett_arc_lifeguard_2015
amos_puckett_arc_lifeguard_2015amos_puckett_arc_lifeguard_2015
amos_puckett_arc_lifeguard_2015Amos Puckett
 
Ποιο είναι το σωστό σουτιέν για κάθε γυναίκα
Ποιο είναι το σωστό σουτιέν για κάθε γυναίκαΠοιο είναι το σωστό σουτιέν για κάθε γυναίκα
Ποιο είναι το σωστό σουτιέν για κάθε γυναίκα
esorouxa mariveta
 
05 viviendo en amor 2da. parte
05 viviendo en amor 2da. parte05 viviendo en amor 2da. parte
05 viviendo en amor 2da. parte
Beit meshobeb TX
 
Hd Prescription
Hd PrescriptionHd Prescription
Hd Prescription
MNDU net
 
RAICES DEL PROTESTANTISMO
RAICES DEL PROTESTANTISMORAICES DEL PROTESTANTISMO
RAICES DEL PROTESTANTISMO
Ricardo Mojica
 
07 resumen de jueces
07 resumen de jueces07 resumen de jueces
07 resumen de jueces
Beit meshobeb TX
 
03 1 juan 2 viviendo en la luz 2da parte
03 1 juan 2 viviendo en la luz 2da parte03 1 juan 2 viviendo en la luz 2da parte
03 1 juan 2 viviendo en la luz 2da parte
Beit meshobeb TX
 
Tiempos primitivos
Tiempos primitivosTiempos primitivos
Tiempos primitivos
Myriam Lucero
 
LO QUE ENSEÑO EL RABINO DE NAZARET
LO QUE ENSEÑO EL RABINO DE NAZARETLO QUE ENSEÑO EL RABINO DE NAZARET
LO QUE ENSEÑO EL RABINO DE NAZARET
Ricardo Mojica
 
A Civilização Grega - 6º Ano (2016)
A Civilização Grega - 6º Ano (2016)A Civilização Grega - 6º Ano (2016)
A Civilização Grega - 6º Ano (2016)
Nefer19
 
H. What do you believe are th e greatest challenges facing the sector or indu...
H. What do you believe are th e greatest challenges facing the sector or indu...H. What do you believe are th e greatest challenges facing the sector or indu...
H. What do you believe are th e greatest challenges facing the sector or indu...
Prashant Surana Jain
 
приказ
приказприказ

Viewers also liked (14)

Holloway Willard C (technical updated)
Holloway Willard C (technical updated)Holloway Willard C (technical updated)
Holloway Willard C (technical updated)
 
Profile Que Lam 2016
Profile Que Lam 2016Profile Que Lam 2016
Profile Que Lam 2016
 
amos_puckett_arc_lifeguard_2015
amos_puckett_arc_lifeguard_2015amos_puckett_arc_lifeguard_2015
amos_puckett_arc_lifeguard_2015
 
Ποιο είναι το σωστό σουτιέν για κάθε γυναίκα
Ποιο είναι το σωστό σουτιέν για κάθε γυναίκαΠοιο είναι το σωστό σουτιέν για κάθε γυναίκα
Ποιο είναι το σωστό σουτιέν για κάθε γυναίκα
 
05 viviendo en amor 2da. parte
05 viviendo en amor 2da. parte05 viviendo en amor 2da. parte
05 viviendo en amor 2da. parte
 
Hd Prescription
Hd PrescriptionHd Prescription
Hd Prescription
 
RAICES DEL PROTESTANTISMO
RAICES DEL PROTESTANTISMORAICES DEL PROTESTANTISMO
RAICES DEL PROTESTANTISMO
 
07 resumen de jueces
07 resumen de jueces07 resumen de jueces
07 resumen de jueces
 
03 1 juan 2 viviendo en la luz 2da parte
03 1 juan 2 viviendo en la luz 2da parte03 1 juan 2 viviendo en la luz 2da parte
03 1 juan 2 viviendo en la luz 2da parte
 
Tiempos primitivos
Tiempos primitivosTiempos primitivos
Tiempos primitivos
 
LO QUE ENSEÑO EL RABINO DE NAZARET
LO QUE ENSEÑO EL RABINO DE NAZARETLO QUE ENSEÑO EL RABINO DE NAZARET
LO QUE ENSEÑO EL RABINO DE NAZARET
 
A Civilização Grega - 6º Ano (2016)
A Civilização Grega - 6º Ano (2016)A Civilização Grega - 6º Ano (2016)
A Civilização Grega - 6º Ano (2016)
 
H. What do you believe are th e greatest challenges facing the sector or indu...
H. What do you believe are th e greatest challenges facing the sector or indu...H. What do you believe are th e greatest challenges facing the sector or indu...
H. What do you believe are th e greatest challenges facing the sector or indu...
 
приказ
приказприказ
приказ
 

Similar to 10 TIPS to Approach a Pregnant lady on Hemodialysis

Anthipertensivos en el embarazo
Anthipertensivos en el embarazoAnthipertensivos en el embarazo
Anthipertensivos en el embarazo
Blanca Rdz Grijalva
 
Liver disorder at pregnancy
Liver disorder at pregnancyLiver disorder at pregnancy
Liver disorder at pregnancy
YashodharaGaur1
 
Renal disease and pregnancy
Renal disease and pregnancyRenal disease and pregnancy
Renal disease and pregnancy
Mohamed E. Elrggal
 
Renal disorders in pregnancy
Renal disorders in pregnancyRenal disorders in pregnancy
Renal disorders in pregnancy
scienthiasanjeevani1
 
(Eng) pregnancy induced hypertension
(Eng) pregnancy induced hypertension(Eng) pregnancy induced hypertension
(Eng) pregnancy induced hypertension
Ryan Mulyana
 
(Eng) pregnancy induced hypertension (1)
(Eng) pregnancy induced hypertension (1)(Eng) pregnancy induced hypertension (1)
(Eng) pregnancy induced hypertension (1)
Ryan Mulyana
 
13. intrahepatic cholestasis of pregnancy3rd jun 15
13. intrahepatic cholestasis of pregnancy3rd jun 1513. intrahepatic cholestasis of pregnancy3rd jun 15
13. intrahepatic cholestasis of pregnancy3rd jun 15
Pawan KB Agrawal
 
Jaundice in pregnancy
Jaundice in pregnancyJaundice in pregnancy
Jaundice in pregnancy
Dr. Ahmad Ali Khan
 
Lecture on Hyperemesis Gravidarum
Lecture on Hyperemesis GravidarumLecture on Hyperemesis Gravidarum
Lecture on Hyperemesis Gravidarum
AthulaKaluarachchi1
 
DIALYSIS IN PREGNANCY.ppsx
DIALYSIS IN PREGNANCY.ppsxDIALYSIS IN PREGNANCY.ppsx
DIALYSIS IN PREGNANCY.ppsx
Krishna Krish Krish
 
Renal and hepatic dis
Renal and hepatic disRenal and hepatic dis
Renal and hepatic dis
Rita Batta
 
Ivf in pcos
Ivf in pcosIvf in pcos
Ivf in pcos
Aboubakr Elnashar
 
CME Hypertension in Pregnancy.pdf
CME Hypertension in Pregnancy.pdfCME Hypertension in Pregnancy.pdf
CME Hypertension in Pregnancy.pdf
yogeswary7
 
Liver diseases in pregnancy (Dr. Amenda Ann Davis)
Liver diseases in pregnancy (Dr. Amenda Ann Davis)Liver diseases in pregnancy (Dr. Amenda Ann Davis)
Liver diseases in pregnancy (Dr. Amenda Ann Davis)
Amenda Ann Davis
 
Renal
RenalRenal
Renal
Aivan Lima
 
Hp mar06 rqectopic
Hp mar06 rqectopicHp mar06 rqectopic
Hp mar06 rqectopic
Abeer Ahmed
 
Gynea.D.Izdihar.L3-Liver disease.pTTTTptx
Gynea.D.Izdihar.L3-Liver disease.pTTTTptxGynea.D.Izdihar.L3-Liver disease.pTTTTptx
Gynea.D.Izdihar.L3-Liver disease.pTTTTptx
hussainAltaher
 
Placenta abruptia
Placenta abruptiaPlacenta abruptia
Placenta abruptia
Raghad Abutair
 
acute kidney injury during pregnancy, challenges in diagnosis and treatment
acute kidney injury during pregnancy, challenges in diagnosis and treatmentacute kidney injury during pregnancy, challenges in diagnosis and treatment
acute kidney injury during pregnancy, challenges in diagnosis and treatment
Marwa Elkaref
 

Similar to 10 TIPS to Approach a Pregnant lady on Hemodialysis (20)

Anthipertensivos en el embarazo
Anthipertensivos en el embarazoAnthipertensivos en el embarazo
Anthipertensivos en el embarazo
 
Liver disorder at pregnancy
Liver disorder at pregnancyLiver disorder at pregnancy
Liver disorder at pregnancy
 
Renal disease and pregnancy
Renal disease and pregnancyRenal disease and pregnancy
Renal disease and pregnancy
 
Renal disorders in pregnancy
Renal disorders in pregnancyRenal disorders in pregnancy
Renal disorders in pregnancy
 
(Eng) pregnancy induced hypertension
(Eng) pregnancy induced hypertension(Eng) pregnancy induced hypertension
(Eng) pregnancy induced hypertension
 
(Eng) pregnancy induced hypertension (1)
(Eng) pregnancy induced hypertension (1)(Eng) pregnancy induced hypertension (1)
(Eng) pregnancy induced hypertension (1)
 
13. intrahepatic cholestasis of pregnancy3rd jun 15
13. intrahepatic cholestasis of pregnancy3rd jun 1513. intrahepatic cholestasis of pregnancy3rd jun 15
13. intrahepatic cholestasis of pregnancy3rd jun 15
 
Jaundice in pregnancy
Jaundice in pregnancyJaundice in pregnancy
Jaundice in pregnancy
 
Lecture on Hyperemesis Gravidarum
Lecture on Hyperemesis GravidarumLecture on Hyperemesis Gravidarum
Lecture on Hyperemesis Gravidarum
 
DIALYSIS IN PREGNANCY.ppsx
DIALYSIS IN PREGNANCY.ppsxDIALYSIS IN PREGNANCY.ppsx
DIALYSIS IN PREGNANCY.ppsx
 
Renal and hepatic dis
Renal and hepatic disRenal and hepatic dis
Renal and hepatic dis
 
Ivf in pcos
Ivf in pcosIvf in pcos
Ivf in pcos
 
CME Hypertension in Pregnancy.pdf
CME Hypertension in Pregnancy.pdfCME Hypertension in Pregnancy.pdf
CME Hypertension in Pregnancy.pdf
 
Liver diseases in pregnancy (Dr. Amenda Ann Davis)
Liver diseases in pregnancy (Dr. Amenda Ann Davis)Liver diseases in pregnancy (Dr. Amenda Ann Davis)
Liver diseases in pregnancy (Dr. Amenda Ann Davis)
 
Renal
RenalRenal
Renal
 
Aflp
AflpAflp
Aflp
 
Hp mar06 rqectopic
Hp mar06 rqectopicHp mar06 rqectopic
Hp mar06 rqectopic
 
Gynea.D.Izdihar.L3-Liver disease.pTTTTptx
Gynea.D.Izdihar.L3-Liver disease.pTTTTptxGynea.D.Izdihar.L3-Liver disease.pTTTTptx
Gynea.D.Izdihar.L3-Liver disease.pTTTTptx
 
Placenta abruptia
Placenta abruptiaPlacenta abruptia
Placenta abruptia
 
acute kidney injury during pregnancy, challenges in diagnosis and treatment
acute kidney injury during pregnancy, challenges in diagnosis and treatmentacute kidney injury during pregnancy, challenges in diagnosis and treatment
acute kidney injury during pregnancy, challenges in diagnosis and treatment
 

More from MNDU net

Thrombotic microangiopathy and the kidney - Dr. Mohamed Mamdouh AbdAlBary
Thrombotic microangiopathy and the kidney -  Dr. Mohamed Mamdouh AbdAlBaryThrombotic microangiopathy and the kidney -  Dr. Mohamed Mamdouh AbdAlBary
Thrombotic microangiopathy and the kidney - Dr. Mohamed Mamdouh AbdAlBary
MNDU net
 
Cardiovascular complications in CKD - Dr. Mohamed Mamdouh AbdAlBary
Cardiovascular complications in CKD - Dr. Mohamed Mamdouh AbdAlBaryCardiovascular complications in CKD - Dr. Mohamed Mamdouh AbdAlBary
Cardiovascular complications in CKD - Dr. Mohamed Mamdouh AbdAlBary
MNDU net
 
Hyperphosphatemia in CKD patients; The Magnitude of The Problem - Prof. Alaa ...
Hyperphosphatemia in CKD patients; The Magnitude of The Problem - Prof. Alaa ...Hyperphosphatemia in CKD patients; The Magnitude of The Problem - Prof. Alaa ...
Hyperphosphatemia in CKD patients; The Magnitude of The Problem - Prof. Alaa ...
MNDU net
 
Hypercalcemia & Hypocalcemia -Dr. Nora Khreba
Hypercalcemia & Hypocalcemia -Dr. Nora KhrebaHypercalcemia & Hypocalcemia -Dr. Nora Khreba
Hypercalcemia & Hypocalcemia -Dr. Nora Khreba
MNDU net
 
Hypokalemia and Hypomagnesemia - Dr. Sherouk El-nagar
Hypokalemia and Hypomagnesemia - Dr. Sherouk El-nagarHypokalemia and Hypomagnesemia - Dr. Sherouk El-nagar
Hypokalemia and Hypomagnesemia - Dr. Sherouk El-nagar
MNDU net
 
How to calculate Sample Size
How to calculate Sample SizeHow to calculate Sample Size
How to calculate Sample Size
MNDU net
 
Towards improving HD efficiency .. HD membranes update - prof. Hesham Elsayed
Towards improving HD efficiency .. HD membranes update - prof. Hesham ElsayedTowards improving HD efficiency .. HD membranes update - prof. Hesham Elsayed
Towards improving HD efficiency .. HD membranes update - prof. Hesham Elsayed
MNDU net
 
What are we missing in CKD-MBD management? - prof. Magdy El Sharkawy
What are we missing in CKD-MBD management? - prof. Magdy El SharkawyWhat are we missing in CKD-MBD management? - prof. Magdy El Sharkawy
What are we missing in CKD-MBD management? - prof. Magdy El Sharkawy
MNDU net
 
Vascular access care .. nephrology perspective - Dr. Tamer El said
Vascular access care .. nephrology perspective - Dr. Tamer El saidVascular access care .. nephrology perspective - Dr. Tamer El said
Vascular access care .. nephrology perspective - Dr. Tamer El said
MNDU net
 
Treatment Of HCV in CKD Patients - Prof. Hussein El-Fishawy
Treatment Of HCV in CKD Patients - Prof. Hussein El-FishawyTreatment Of HCV in CKD Patients - Prof. Hussein El-Fishawy
Treatment Of HCV in CKD Patients - Prof. Hussein El-Fishawy
MNDU net
 
Updates in management of membranous nephropathy - Dr. Mohammed Kamal Nassar
Updates in management of membranous nephropathy - Dr. Mohammed Kamal NassarUpdates in management of membranous nephropathy - Dr. Mohammed Kamal Nassar
Updates in management of membranous nephropathy - Dr. Mohammed Kamal Nassar
MNDU net
 
Renal transplantation in patients with lupus nephritis - prof. Ayman Refaie
Renal transplantation in patients with lupus nephritis - prof. Ayman Refaie Renal transplantation in patients with lupus nephritis - prof. Ayman Refaie
Renal transplantation in patients with lupus nephritis - prof. Ayman Refaie
MNDU net
 
Obstacles for organ donation and transplantation in developing countries - Pr...
Obstacles for organ donation and transplantation in developing countries - Pr...Obstacles for organ donation and transplantation in developing countries - Pr...
Obstacles for organ donation and transplantation in developing countries - Pr...
MNDU net
 
Rate of kidney function decline (KFD) and subsequent ESRD - prof. Ahmed Shokr
Rate of kidney function decline (KFD) and subsequent ESRD - prof. Ahmed Shokr Rate of kidney function decline (KFD) and subsequent ESRD - prof. Ahmed Shokr
Rate of kidney function decline (KFD) and subsequent ESRD - prof. Ahmed Shokr
MNDU net
 
3rd Day Quiz Answer - Dr. Emad Magdy
3rd Day Quiz Answer - Dr. Emad Magdy 3rd Day Quiz Answer - Dr. Emad Magdy
3rd Day Quiz Answer - Dr. Emad Magdy
MNDU net
 
Obesity Related Glomerulopathy (ORG) - prof. Salem Eldeeb
Obesity Related Glomerulopathy (ORG) - prof. Salem EldeebObesity Related Glomerulopathy (ORG) - prof. Salem Eldeeb
Obesity Related Glomerulopathy (ORG) - prof. Salem Eldeeb
MNDU net
 
Lupus Nephritis Dilemma - Prof. Mohsen El Kosi
Lupus Nephritis Dilemma - Prof. Mohsen El KosiLupus Nephritis Dilemma - Prof. Mohsen El Kosi
Lupus Nephritis Dilemma - Prof. Mohsen El Kosi
MNDU net
 
Incremental Heamodialysis .. Who Fit ? - prof. Amir el-okeily
Incremental Heamodialysis .. Who Fit ? - prof. Amir el-okeilyIncremental Heamodialysis .. Who Fit ? - prof. Amir el-okeily
Incremental Heamodialysis .. Who Fit ? - prof. Amir el-okeily
MNDU net
 
Hypertension 2018 Guidelines - prof. Tarek Medhat
Hypertension 2018 Guidelines - prof. Tarek Medhat Hypertension 2018 Guidelines - prof. Tarek Medhat
Hypertension 2018 Guidelines - prof. Tarek Medhat
MNDU net
 
Haemodialysis or Haemodifiltration? - Prof. Mohsen El Kosi
Haemodialysis or Haemodifiltration? - Prof. Mohsen El KosiHaemodialysis or Haemodifiltration? - Prof. Mohsen El Kosi
Haemodialysis or Haemodifiltration? - Prof. Mohsen El Kosi
MNDU net
 

More from MNDU net (20)

Thrombotic microangiopathy and the kidney - Dr. Mohamed Mamdouh AbdAlBary
Thrombotic microangiopathy and the kidney -  Dr. Mohamed Mamdouh AbdAlBaryThrombotic microangiopathy and the kidney -  Dr. Mohamed Mamdouh AbdAlBary
Thrombotic microangiopathy and the kidney - Dr. Mohamed Mamdouh AbdAlBary
 
Cardiovascular complications in CKD - Dr. Mohamed Mamdouh AbdAlBary
Cardiovascular complications in CKD - Dr. Mohamed Mamdouh AbdAlBaryCardiovascular complications in CKD - Dr. Mohamed Mamdouh AbdAlBary
Cardiovascular complications in CKD - Dr. Mohamed Mamdouh AbdAlBary
 
Hyperphosphatemia in CKD patients; The Magnitude of The Problem - Prof. Alaa ...
Hyperphosphatemia in CKD patients; The Magnitude of The Problem - Prof. Alaa ...Hyperphosphatemia in CKD patients; The Magnitude of The Problem - Prof. Alaa ...
Hyperphosphatemia in CKD patients; The Magnitude of The Problem - Prof. Alaa ...
 
Hypercalcemia & Hypocalcemia -Dr. Nora Khreba
Hypercalcemia & Hypocalcemia -Dr. Nora KhrebaHypercalcemia & Hypocalcemia -Dr. Nora Khreba
Hypercalcemia & Hypocalcemia -Dr. Nora Khreba
 
Hypokalemia and Hypomagnesemia - Dr. Sherouk El-nagar
Hypokalemia and Hypomagnesemia - Dr. Sherouk El-nagarHypokalemia and Hypomagnesemia - Dr. Sherouk El-nagar
Hypokalemia and Hypomagnesemia - Dr. Sherouk El-nagar
 
How to calculate Sample Size
How to calculate Sample SizeHow to calculate Sample Size
How to calculate Sample Size
 
Towards improving HD efficiency .. HD membranes update - prof. Hesham Elsayed
Towards improving HD efficiency .. HD membranes update - prof. Hesham ElsayedTowards improving HD efficiency .. HD membranes update - prof. Hesham Elsayed
Towards improving HD efficiency .. HD membranes update - prof. Hesham Elsayed
 
What are we missing in CKD-MBD management? - prof. Magdy El Sharkawy
What are we missing in CKD-MBD management? - prof. Magdy El SharkawyWhat are we missing in CKD-MBD management? - prof. Magdy El Sharkawy
What are we missing in CKD-MBD management? - prof. Magdy El Sharkawy
 
Vascular access care .. nephrology perspective - Dr. Tamer El said
Vascular access care .. nephrology perspective - Dr. Tamer El saidVascular access care .. nephrology perspective - Dr. Tamer El said
Vascular access care .. nephrology perspective - Dr. Tamer El said
 
Treatment Of HCV in CKD Patients - Prof. Hussein El-Fishawy
Treatment Of HCV in CKD Patients - Prof. Hussein El-FishawyTreatment Of HCV in CKD Patients - Prof. Hussein El-Fishawy
Treatment Of HCV in CKD Patients - Prof. Hussein El-Fishawy
 
Updates in management of membranous nephropathy - Dr. Mohammed Kamal Nassar
Updates in management of membranous nephropathy - Dr. Mohammed Kamal NassarUpdates in management of membranous nephropathy - Dr. Mohammed Kamal Nassar
Updates in management of membranous nephropathy - Dr. Mohammed Kamal Nassar
 
Renal transplantation in patients with lupus nephritis - prof. Ayman Refaie
Renal transplantation in patients with lupus nephritis - prof. Ayman Refaie Renal transplantation in patients with lupus nephritis - prof. Ayman Refaie
Renal transplantation in patients with lupus nephritis - prof. Ayman Refaie
 
Obstacles for organ donation and transplantation in developing countries - Pr...
Obstacles for organ donation and transplantation in developing countries - Pr...Obstacles for organ donation and transplantation in developing countries - Pr...
Obstacles for organ donation and transplantation in developing countries - Pr...
 
Rate of kidney function decline (KFD) and subsequent ESRD - prof. Ahmed Shokr
Rate of kidney function decline (KFD) and subsequent ESRD - prof. Ahmed Shokr Rate of kidney function decline (KFD) and subsequent ESRD - prof. Ahmed Shokr
Rate of kidney function decline (KFD) and subsequent ESRD - prof. Ahmed Shokr
 
3rd Day Quiz Answer - Dr. Emad Magdy
3rd Day Quiz Answer - Dr. Emad Magdy 3rd Day Quiz Answer - Dr. Emad Magdy
3rd Day Quiz Answer - Dr. Emad Magdy
 
Obesity Related Glomerulopathy (ORG) - prof. Salem Eldeeb
Obesity Related Glomerulopathy (ORG) - prof. Salem EldeebObesity Related Glomerulopathy (ORG) - prof. Salem Eldeeb
Obesity Related Glomerulopathy (ORG) - prof. Salem Eldeeb
 
Lupus Nephritis Dilemma - Prof. Mohsen El Kosi
Lupus Nephritis Dilemma - Prof. Mohsen El KosiLupus Nephritis Dilemma - Prof. Mohsen El Kosi
Lupus Nephritis Dilemma - Prof. Mohsen El Kosi
 
Incremental Heamodialysis .. Who Fit ? - prof. Amir el-okeily
Incremental Heamodialysis .. Who Fit ? - prof. Amir el-okeilyIncremental Heamodialysis .. Who Fit ? - prof. Amir el-okeily
Incremental Heamodialysis .. Who Fit ? - prof. Amir el-okeily
 
Hypertension 2018 Guidelines - prof. Tarek Medhat
Hypertension 2018 Guidelines - prof. Tarek Medhat Hypertension 2018 Guidelines - prof. Tarek Medhat
Hypertension 2018 Guidelines - prof. Tarek Medhat
 
Haemodialysis or Haemodifiltration? - Prof. Mohsen El Kosi
Haemodialysis or Haemodifiltration? - Prof. Mohsen El KosiHaemodialysis or Haemodifiltration? - Prof. Mohsen El Kosi
Haemodialysis or Haemodifiltration? - Prof. Mohsen El Kosi
 

Recently uploaded

Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
VarunMahajani
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIONDACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
DR SETH JOTHAM
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
NEHA GUPTA
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 

Recently uploaded (20)

Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIONDACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 

10 TIPS to Approach a Pregnant lady on Hemodialysis

  • 1. 10 TIPS to Approach a Pregnant lady on Hemodialysis Emad Magdy Shawky Assistant lecturer of Nephrology MNDU Hemodialysis Course, 22th DEC. 2016
  • 2. CHANCE Kidney Int. 2016 May;89(5) 1 Hormonal changes (Estrogen- progesterone- LH- Prolactine)  Anovulation ( with or without Amenorrhea)  Endometrial changes
  • 3. CHANCE Kidney Int. 2016 May;89(5) 1 The Miracle Continues Against All Odds
  • 4. CHANCE1 Increasing incidence  May reach 7% of women on CHD rising from 1% 1980 (Improving Dx service, better anemia control)  More with residual renal function.  Less with PD. Increasing survival rates  1st successful 1971  30-50% increasing dialysis dose  85% premature  35% LBW ( < 2kg)  Common complications : Respiratory distress- CP- Congenital anomalies Kidney Int. 2016 May;89(5)
  • 5. CONTRACEPTION2 Medical, Ethical, And Emotional Complexities Am J Kidney Dis. 2015 Dec;66(6):951-61
  • 7. CONTRACEPTION2 Counselling tips for dialysis or pre-dialysis patients who wish to undertake a pregnancy  Counselling on pregnancy and contraception should be included in the approach to all women in childbearing age who start dialysis (not graded).  The prognostic markers allowing quantification of the probability of a successful pregnancy are only partially known. Residual kidney function and normotension are favourable prognostic factors (not graded).  Counselling should also include the fact that outcomes of pregnancy are better after transplantation than on dialysis (strong suggestion from large studies in transplanted patients, and from Registries).
  • 8. CONTRACEPTION2 Historically, renal disease was considered a contraindication to pregnancy, but now many pregnant women with CKD have successful outcomes Am J Kidney Dis. 2015 Dec;66(6):951-61 The key pre-pregnancy factors predicting outcome include the following: Degree of renal impairment rather than the aetiology of renal disease. Control of hypertension Degree of proteinuria
  • 10. CONTRACEPTION2 • HTN, PET, Anemia, progression to ESRD • Placental Hge, polyhydramnios, PROM Maternal • Prematurity, LBW, IUGR, CP, Cong anomalies • Neonatal death, abortion Fetal Hippokratia. 2011 Jan; 15 (Suppl 1): 8–12.
  • 14. CONTRACEPTION2 IUD Bleeding- Infection Oral contraceptives Hypercoagulability (access) Barriers Safety ACKD Journal, Vol 20, No 3 (May), 2013
  • 15. CONTRACEPTION2 IUD Bleeding- Infection Oral contraceptives Hypercoagulability (access) Barriers Safety ACKD Journal, Vol 20, No 3 (May), 2013
  • 16. Difficult  Pregnancy is often unexpected  Symptoms in the early phase may mimic different diseases and complications of dialysis.  Serum levels of beta-HCG may be increased even in the absence of pregnancy.  Irregular menstrual cycles and anovulation are common in women on dialysis,thus making the calculation of gestational age based upon the last menstrual cycle unreliable. In this context, early ultrasonography should be used to verify the presence of a viable foetus and to calculate the gestational age. Gianfranco Manisco,et al. clin kidney J (2015) 3 Diagnosis of pregnancy in dialysis
  • 17. Challenges In Prescription4 Plasma volume Increased by 30% >> hemodilution>>anemia WT gain rate plasma vol plus fetal and placental develop Polyhydramnios as high BUN>>fetal osmotic diuresis  Bone and mineral metabolism placenta converts some 25- hydroxyvitamin D3 to 1,25-dihydroxyvitamin D3>>adjustment of vitamin D , Ca supplement Respiratory alkalosis hyperventilation (progest mechanical) – hyperemesis>>> compensation by M.Acidosis EPO resistance , cytokine release >> anemia
  • 18. DOSE AND ADEQUACY4.a. Nephrol Dial Transplant (2015) 0: 1–20 Target BUN < 50 mg/dL or even < 45 mg/dL
  • 19. DOSE AND ADEQUACY4.a. Recently, the relationship between dialysis intensity and outcomes has become clearer, with increased dialysis delivery becoming standard practice and nocturnal hemodialysis potentially providing superior fertility and outcomes. Shilpanjali Jesudson, et al. Clin J Am Soc Nephrol 9: 143–149, 2014.
  • 20. DOSE AND ADEQUACY Hippokratia. 2011 Jan; 15 (Suppl 1): 8–12. 4.a.
  • 21. J Am Soc Nephrol. 2014; 25:1103–1109. 4.a.
  • 22. J Am Soc Nephrol. 2014; 25:1103–1109. 4.a.
  • 23. J Am Soc Nephrol. 2014; 25:1103–1109. 4.a.
  • 24. Dialyzer type, ultrafiltration volume Small surface area dialysers Reduce UF rate per session Avoid hypotension Avoid abrupt osmolarity changes 4.b. High surface area membranes
  • 25. Dialyzer type, ultrafiltration volume Dry BW assessment Predicted Wt gain: after 3m>> 0.5 Kg/wk Clinical: Bp control, (edema not reliable) Hematocrit & Albumin levels Measure Hematocrit & Albumin at the initial first- trimester visit. 4.b. A rise in either value strongly suggests intravascular volume contraction, Opposite is not trueAdvances in Chronic Kidney Disease, Vol 20, No 3 (May), 2013
  • 26. Heparin Pregnancy is a hypercoagulability state so theoretically there are increased requirements but it is not a rule. 4.c. Individualization Hemodialysis International 2016; 20:339–348.
  • 27. Dialysate constituents • 3 meq/l • Intensive dialysis with risk of hypokalemia • <25 meq/l • Target serum18-22 mmol/l • 135 mmol/l 4.d. Hemodialysis International 2016; 20:339–348 .
  • 28. Minerals and water soluble vitamins Give at increased doses, because they can be partially removed by intensive dialysis. Folic acid at a higher dose of 5 mg daily if on dialysis 4.e. Hemodialysis International 2016; 20:339–348
  • 29. BMD Phosphate: monitored frequently- may stop phosphate binders or need supplementation (important to fetal skeletal development) Calcium: increase dialysate calcium to 1.75 mmol/l – oral supplementation (1-2 g/d)- take care of hyper or hypocalcemia 5 placenta converts some 25-hydroxyvitamin D3 to 1,25-dihydroxyvitamin D3 Kidney Int. 2016 May;89(5)
  • 30. Anemia6 Target : 11g/dl. EPO : increase dose by 50%. Iron : monitored monthly ( IV supp). CBC weekly. <8g/dl>> blood trasnfusion. Kidney Int. 2016 May;89(5)
  • 31. Hypertension And Superimposed PET Target BP 110-140/80-90 mmHg 7
  • 32. Superimposed Preeclampsia Kavitha Vellanki. Advances in Chronic Kidney Disease, 2013. Difficult Diagnosis 7  Already patient has renal impairment ± proteinuria ± the absence of significant urine output if late stage CKD or 5D  Hypertension, ↓ GFR or proteinuria can be due to progression of the renal disorder rather than superimposed preeclampsia
  • 33. When to suspect pre-eclampsia?  Unexplained rise in BP not responding to fluid removal & drugs  Development of classic preeclampsia symptoms (visual abnormalities severe headache, epigastric pain & hyper- reflexia)  Fetal growth restriction and abnormal umbilical artery blood flow (uterine artery doppler).  Laboratory abnormalities consistent with the HELLP syndrome & thrombocytopenia 7 after 20 weeks of pregnancy Advances in Chronic Kidney Disease, Vol 20, No 3 (May), 2013 Aspirin (75–150 mg/day) The aim of aspirin is for the prevention of preeclampsia or perinatal death
  • 34. Fetal Assessment Serial ultrasound examinations are important for the early detection fetal growth restriction Assessment of the fetal heart rate (particularly during the last portion of a session) 8 Kidney Int. 2016 May;89(5) Maternal haemodynamic instability may compromise the uteroplacental circulation and may be associated with the induction of uterine contractions
  • 35. Nutrition9 Attention to nutritional considerations is essential for a successful pregnancy because malnutrition is common in pregnancies of ESRD patients G. Manisco et al. Clin Kidney J (2015) 0: 1–7
  • 36. Nutrition Provide protein intake of 1.2–1.4 g/kg pre-pregnancy weight/day + 20 g/day Provide calories intake of 25–35 kcal/kg/pregnant weight/day Provide water-soluble vitamins supplementation The main vitamins to be supplemented are vitamin C, thiamine, riboflavin, niacin and vitamin B6 9 G. Manisco et al. Clin Kidney J (2015) 0: 1–7
  • 37. Breast Feeding10 PLoS One. 2015 Nov 16;10(11)  Significant variations in breast milk composition between pre- and post-HD samples suggest that breastfeeding might be preferably performed after dialysis treatment.  In summary, our findings indicate that breastfeeding can be considered a viable option for newborns of mothers on dialysis.